| 104586-3 | Child and adolescent psychiatry Telephone encounter Note | DOC.ONTOLOGY |
| 104587-1 | Child and adolescent psychiatry Telehealth Note | DOC.ONTOLOGY |
| 104588-9 | Emergency medicine team Conference note | DOC.ONTOLOGY |
| 104589-7 | Heart failure Telehealth Note | DOC.ONTOLOGY |
| 10459-6 | Alpha-1-Fetoprotein Ag (Tissue, qualitative, immune stain) | PATH |
| 104590-5 | Medical Aid in Dying Telehealth Note | DOC.ONTOLOGY |
| 104591-3 | Vascular surgery Letter | DOC.ONTOLOGY |
| 104592-1 | Cardiac surgery Letter | DOC.ONTOLOGY |
| 104593-9 | Oncology Letter | DOC.ONTOLOGY |
| 104594-7 | Diabetology nurse practitioner Outpatient Note | DOC.ONTOLOGY |
| 104595-4 | Dengue virus Ab.IgG and IgM and NS1 Ag panel - Serum or Plasma | PANEL.MICRO |
| 104596-2 | Phenytoin and Phenobarbital panel - Serum | PANEL.DRUG/TOX |
| 104597-0 | Glucose (Venous Blood, glucometer) | CHEM |
| 104598-8 | Glucose (Arterial Blood, glucometer) | CHEM |
| 104599-6 | Fungal susceptibility panel - Isolate (minimum inhibitory concentration (mic)) | PANEL.MICRO |
| 1046-2 | H NOS Ab from Donor (qualitative) | BLDBK |
| 10460-4 | Lactalbumin alpha Ag (Tissue, qualitative, immune stain) | PATH |
| 104600-2 | MC5 metabolite of Tianeptine (qualitative, lc/ms/ms) | DRUG/TOX |
| 104601-0 | No harm related to unintentional sterile field/wound contamination (qualitative) | SURVEY.PNDS |
| 104602-8 | Borrelia burgdorferi B31 IgM Ab (qualitative, line blot) | MICRO |
| 104603-6 | Borrelia burgdorferi B31 IgG Ab (qualitative, line blot) | MICRO |
| 104604-4 | Coenzyme Q10 (Tissue) | CHEM |
| 104605-1 | Alert | DOC.ONTOLOGY |
| 104606-9 | MDS v3.0 - RAI v1.19.1 - Nursing home discharge (ND) item set during assessment period | PANEL.SURVEY.CMS |
| 104607-7 | MDS v3.0 - RAI v1.19.1 - Swing Bed discharge (SD) item set during assessment period | PANEL.SURVEY.CMS |
| 104608-5 | MDS v3.0 - RAI v1.19.1 - Interim Payment Assessment (IPA) item set during assessment period | PANEL.SURVEY.CMS |
| 104609-3 | MDS v3.0 - RAI v1.19.1 - Swing bed PPS (SP) item set during assessment period | PANEL.SURVEY.CMS |
| 10461-2 | Alpha-1-Antichymotrypsin Ag (Tissue, qualitative, immune stain) | PATH |
| 104610-1 | Monkeypox virus clade II and Orthopoxvirus.non-variola DNA in Specimen (naa with probe detection) | MICRO |
| 104611-9 | Disparate health care quality PhenX | PANEL.PHENX |
| 104612-7 | Was there ever a time when you would have gotten better medical care if you had belonged to a different race or ethnic group (qualitative) | PHENX |
| 104613-5 | Since you speak a language other than English at home, we are interested in your own opinion of how well you speak English. Would you say you speak English (qualitative) | PHENX |
| 104614-3 | English proficiency PhenX | PANEL.PHENX |
| 104619-2 | Spermatozoa.abnormal chromatin (Semen, flow cytometry (fc)) | MOLPATH |
| 10462-0 | Alpha 1 antitrypsin Ag (Tissue, qualitative, immune stain) | PATH |
| 104620-0 | DNA fragmentation index (Semen, flow cytometry (fc)) | MOLPATH |
| 104621-8 | High DNA stainability (Semen, flow cytometry (fc)) | MOLPATH |
| 104625-9 | Static oxidation-reduction potential in 5 minutes Semen --normalized to sperm concentration | FERT |
| 104626-7 | Methadone Confirmatory panel - Urine | PANEL.DRUG/TOX |
| 104627-5 | 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) (Urine, qualitative, gas chromatography-mass spectrometry) | DRUG/TOX |
| 104628-3 | Methadone (Urine, gas chromatography-mass spectrometry) | DRUG/TOX |
| 104629-1 | Metanephrine in 24 hour Urine (lc/ms/ms) | CHEM |
| 10463-8 | Amyloid A component Ag (Tissue, qualitative, immune stain) | PATH |
| 104630-9 | Metanephrines in 24 hour Urine (lc/ms/ms) | CHEM |
| 104631-7 | Normetanephrine in 24 hour Urine (lc/ms/ms) | CHEM |
| 104632-5 | Metanephrine, Normetanephrine and Total metanephrines panel - 24 hour Urine | PANEL.CHEM |
| 104633-3 | US Guidance for aspiration of ganglion cyst of Unspecified body region | RAD |
| 104634-1 | Continuous glucose monitor device Reporting Period start - Reported | CLIN |
| 104635-8 | Continuous glucose monitor device Reporting Period end - Reported | CLIN |
| 104636-6 | Days continuous glucose monitor device worn Reporting Period Estimated | CLIN |